Publications by authors named "Fuminari Yamaguchi"

Claim this Profile
S
Salt loading with unilateral nephrectomy accelerates decline in glomerular filtration rate in the hypertensive, obese, type 2 diabetic SDT fatty rat model of diabetic kidney disease.
Yuichi Shinozaki, Yuko Katayama, Fuminari Yamaguchi, Tomohisa Suzuki, Kana Watanabe

Clin Exp Pharmacol Physiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
Hiroaki Yashiro, Kenichi Hamagami, Hideyuki Hiyoshi, Jun Sugama, Kazue Tsuchimori, Fuminari Yamaguchi

Diabetes Obes Metab· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Keiji Kusumoto, Hideki Igata, Mami Ojima, Ayako Tsuboi, Mitsuaki Imanishi, Fuminari Yamaguchi

Eur J Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis